Emerging treatments for advanced cholangiocarcinoma: Addressing the knowledge gap. Background: HCC is a leading cause of cancer-related deaths worldwide. LEN is now a first-line treatment option for ...

The pharmaceutical industry is facing growing pressure to make drug development more patient-focused. Traditionally, most observational research has been derived from clinical and payer data, but has ...